Mitochondrial gene mutation, but not large-scale deletion, is a feature of colorectal carcinomas with mitochondrial microsatellite instability

International Journal of Cancer

Volumn 83, Issue 5, 1999, Pages 625-629

  Habano, Wataru ^a   Sugai, Tamotsu ^a   Yoshida, Toru ^a   Nakamura, Shin ichi ^a  

^a IWATE MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MITOCHONDRIAL DNA; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE;

ARTICLE; CARCINOGENESIS; COLORECTAL CARCINOMA; CONTROLLED STUDY; FRAMESHIFT MUTATION; GENE MUTATION; HUMAN; HUMAN TISSUE; MICROSATELLITE INSTABILITY; MISSENSE MUTATION; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM;

CARCINOMA; COLORECTAL NEOPLASMS; DNA, MITOCHONDRIAL; FRAMESHIFT MUTATION; HUMANS; MICROSATELLITE REPEATS; MUTATION, MISSENSE; NADH DEHYDROGENASE; NEOPLASM PROTEINS; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL;

EID: 0032729633     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19991126)83:5<625::AID-IJC10>3.0.CO;2-N     Document Type: Article

References (21)

1. ANDERSON, S. and 13 OTHERS, Sequence and organization of the human mitochondrial genome. Nature (Lond.), 290, 457-465 (1981).
2. BANDY, B. and DAVISON, A.J., Mitochondrial mutations may increase oxidative stress: implications for carcinogenesis and aging? Free Radicals Biol. Med., 8, 523-539 (1990).
3. BARNES, W.M., PCR amplification of up to 35-kb DNA with high fidelity and high yield from γ bacteriophage templates. Proc. natl. Acad. Sci. (Wash.), 91, 2216-2220 (1994).
4. BURGART, L.J., ZHENG, J., SHU, Q., STRICKLER, J.G. and SHIBATA, D., Somatic mitochondrial mutation in gastric cancer. Amer. J. Pathol., 147, 1105-1111 (1995).
5. CHUNG, D.C. and RUSTGI, A.K., DNA mismatch repair and cancer. Gastroenterology, 109, 1685-1699 (1995).
6. HABANO, W., NAKAMURA, S. and SUGAI, T., Microsatellite instability in the mitochondrial DNA of colorectal carcinomas: evidence for mismatch repair systems in mitochondrial genome. Oncogene, 17, 1931-1937 (1998a).
7. HABANO, W., SUGAI, T. and NAKAMURA, S., Mismatch repair deficiency leads to a unique mode of colorectal tumorigenesis characterized by intratumoral heterogeneity. Oncogene, 16, 1259-1265 (1998b).
8. HABANO, W., SUGAI, T., NAKAMURA, S. and YOSHIDA, T., A novel method for gene analysis of colorectal carcinomas using a crypt isolation technique. Lab. Invest., 74, 933-940 (1996).
9. HORTON, T.M., PETROS, J.A., HEDDI, A., SHOFFNER, J., KAUFMAN, A.E., GRAHAM, JR. S.D., GRAMLICH, T. and WALLACE, D.C., Novel mitochondrial DNA deletion found in a renal cell carcinoma. Genes Chromosomes Cancer, 15, 95-101 (1996).
10. MITA, S., RIZZUTO, R., MORAES, C.T., SHANSKE, S., ARNAUDO, E., FABRIZI, G.M., KOGA, Y., DIMAURO, S. and SCHON, E.A., Recombination via flanking direct repeats is a major cause of large-scale deletions of human mitochondrial DNA. Nucleic Acid Res., 18, 561-567 (1990).
11. OZAWA, T., Mechanism of somatic mitochondrial DNA mutations associated with age and diseases. Biochim. biophys. Acta, 1271, 177-189 (1995).
12. PARSONS, T.J., MUNIEC, D.S., SULLIVAN, K., WOODYAT T., N., ALLISTON-GREINER, R., WILSON, M.R., BERRY, D.L., HOLLAND, K.A., WEEDN, V.W., GILL, P. and HOLLAND, M.M., A high observed substitution rate in the human mitochondrial DNA control region. Nature (Genet.), 15, 363-367 (1997).
13. POLYAK, K., LI, Y., ZHU, H., LENGAUER, C., WILLSON, J.K.V., MARKOWITZ, S.D., TRUSH, M.A., KINZLER, K.W. and VOGELSTEIN, B., Somatic mutations of the mitochondrial genome in human colorectal tumours. Nature (Genet.), 20, 291-293 (1998).
14. REENAN, R.A.G. and KOLODNER, R.D., Characterization of insertion mutations in the Saccharomyces cerevisiae MSH1 and MSH2 genes: evidence for separate mitochondrial and nuclear functions. Genetics, 132, 975-985 (1992).
15. SAGER, R., Genetic suppression of tumor formation. Adv. Cancer Res., 44, 43-68 (1985).
16. SHARP, M.G.F., ADAMS, S.M., WALKER, R.A., BRAMMAR, W.J. and VARLEY, J.M., Differential expression of the mitochondrial gene cytochrome oxidase II in benign and malignant breast tissue. J. Pathol., 168, 163-168 (1992).
17. VOGELSTEIN B., FEARON, E.R., HAMILTON, S.R., KERN, S.E., PREISINGER, A.C., LEPPERT, M., NAKAMURA, Y., WHITE, R., SMITS, A.M.M. and BOS, J.L., Genetic alterations during colorectal tumor development. N. Eng. J. Med., 319, 525-532 (1988).
18. WALLACE, D.C., Diseases of the mitochondrial DNA. Ann. Rev. Biochem., 61, 1175-1212 (1992).
19. WALLACE, D.C., ZHENG, X., LOTT, M.T., SHOFFNER, J.M., HODGE, J.A., KELLEY, R.I., EPSTEIN, C.M. and HOPKINS, L.C., Familial mitochondrial encephalomyopathy (MERRF): Genetic, pathophysiological, and biochemical characterization of a mitochondrial DNA disease. Cell, 55, 601-610 (1988).
20. WILKIE, D., EVANS, I.H., EGILSSON, V., DIALA, E.S. and COLLIER, D., Mitochondria, cell surface, and carcinogenesis. Int. Rev. Cytol., 15 (SUPPL.), 157-189 (1983).
21. YAMAMOTO, H., SAWAI, H. and PERUCHO, M., Frameshift somatic mutations in gastrointestinal cancer of the microsatellite mutator phenotype. Cancer Res., 57, 4420-4426 (1997).